HIPAA Considerations for AI Medical Transcription

HIPAA Applies to AI Transcription—Fully and Without Exception

HIPAA’s requirements apply to any workflow that involves the creation, receipt, maintenance, or transmission of protected health information (PHI). AI medical transcription involves all four: it receives dictated audio containing PHI, creates a clinical document containing PHI, maintains PHI during the processing and QA review period, and transmits the completed document back to the covered entity. ^[1]

The fact that the initial processing step is performed by artificial intelligence rather than a human does not diminish or modify these obligations. If anything, AI transcription workflows introduce additional compliance considerations—related to data handling, model training, audio retention, and accuracy—that traditional transcription workflows do not raise.

The Business Associate Requirement

Under HIPAA, any entity that performs services for a covered entity that require access to PHI is a business associate. AI transcription vendors are business associates. ^[2] The consequences of this classification are specific and non-negotiable:

• A Business Associate Agreement (BAA) must be executed before any PHI is shared with the vendor

• The BAA must specify permissible uses and disclosures of PHI

• The BAA must require the vendor to implement appropriate safeguards

• The BAA must obligate the vendor to report security incidents and breaches

• The BAA must require the vendor to ensure that subcontractors who access PHI also execute BAAs

• The BAA must address the return or destruction of PHI at contract termination

Organizations that share PHI with an AI transcription vendor without a BAA are in direct violation of the HIPAA Privacy Rule. The penalty tiers for HIPAA violations range from $100 to $50,000 per violation (per affected record), with annual caps up to $1.9 million per violation category. ^[3]

Key HIPAA Provisions in AI Transcription Workflows

The Privacy Rule: Minimum Necessary Standard

The Privacy Rule’s minimum necessary standard requires that only the minimum PHI necessary to accomplish the intended purpose be used or disclosed. ^[4] In AI transcription, this principle has practical implications:

• Audio recordings should contain only the clinical content necessary for transcription—not ambient conversation, personal discussions, or information unrelated to the documented encounter

• AI processing systems should access only the data required for the transcription function—not patient records, historical documentation, or other PHI beyond the current dictation

• Human QA reviewers should have access only to the documents they are reviewing—not to patient records beyond the current transcription task

The Security Rule: Technical Safeguards for AI Transcription

The Security Rule requires covered entities and business associates to implement technical safeguards to protect electronic PHI (ePHI). ^[5] For AI transcription workflows, the relevant technical safeguards include:

Audio Files as PHI: A Frequently Overlooked Risk

Physician dictation audio files are PHI. They contain the physician’s voice, patient identifiers, clinical content, and often information sufficient to identify both the provider and the patient. Audio files must be handled with the same rigor as the transcribed documents they produce. ^[6]

Key questions for AI transcription vendors regarding audio handling:

• Is the audio encrypted during transmission to the vendor’s processing environment?

• Is the audio encrypted at rest in the vendor’s storage environment?

• Where is the audio stored—domestic servers, international servers, third-party cloud infrastructure?

• How long is audio retained after transcription? What is the deletion timeline and process?

• Is the audio used for AI model training? If so, how is consent managed and how is PHI protected?

The use of dictation audio for AI model training is a particularly sensitive issue. If a vendor uses physician dictations to improve its AI models without appropriate data handling agreements and consent, this may constitute an unauthorized use of PHI beyond the scope of the transcription function—a potential HIPAA violation and a reputational risk for the covered entity. ^[7]

The Breach Notification Rule

The HIPAA Breach Notification Rule requires covered entities to notify affected individuals, the Department of HHS, and in some cases the media, following a breach of unsecured PHI. ^[8] Business associates must notify covered entities within 60 days of discovering a breach.

AI transcription workflows introduce breach risk through:

• Unauthorized access to audio files or transcribed documents

• Transmission of PHI to unintended recipients (routing errors in document delivery)

• Vendor security incidents affecting stored PHI

• Inadvertent PHI exposure through AI system logs or error outputs

Organizations should confirm that their AI transcription vendors have documented breach detection, investigation, and notification procedures—and that those procedures meet the 60-day notification requirement.

State Privacy Laws and AI Transcription

Several states have enacted health privacy laws that are more stringent than HIPAA. California’s Confidentiality of Medical Information Act (CMIA), New York’s SHIELD Act, and a growing number of state consumer data protection laws impose requirements that may affect AI transcription deployments—including stricter consent requirements, shorter breach notification windows, and more expansive definitions of health information. ^[9]

Organizations operating in multiple states, or serving patients across state lines (including telehealth providers), must conduct state-level privacy compliance reviews as part of AI transcription deployment planning. A BAA that meets HIPAA requirements may not satisfy all state law requirements.

Evaluating Vendor HIPAA Compliance: A Due Diligence Checklist

Frequently Asked Questions

If our AI transcription vendor is based outside the United States, what additional HIPAA considerations apply?

HIPAA applies based on the location of the covered entity and the PHI—not the location of the business associate. An international vendor can be a HIPAA business associate, but organizations must ensure that the transfer of PHI outside the United States does not violate applicable export restrictions or create enforcement gap risks. Additional contractual provisions may be required, and some state laws prohibit international transfer of health information without explicit patient consent. ^[10]

Is a BAA sufficient to ensure HIPAA compliance with an AI transcription vendor?

A BAA is necessary but not sufficient. The BAA establishes the contractual obligation; due diligence on the vendor’s actual security practices, data handling, and breach response capabilities is required to confirm that the vendor is in a position to fulfill those obligations. A BAA with a non-compliant vendor does not protect the covered entity from liability for the vendor’s compliance failures.

Do patients need to be informed that AI is used in their documentation?

HIPAA does not currently require disclosure that AI tools are used in documentation processing. The Notice of Privacy Practices must describe how PHI is used, but the specific tools used for documentation are generally not required to be disclosed. Some organizations choose to include AI transcription disclosure in their Notice of Privacy Practices as a transparency best practice. State law requirements vary. ^[11]

How should we handle a situation where an AI transcription error results in incorrect PHI in the medical record?

Under HIPAA’s amendment provision (45 CFR §164.526), patients have a right to request amendment of inaccurate PHI. When a documentation error is identified—whether from AI hallucination or any other source—the covered entity should: (1) amend the record using the EHR’s amendment or addendum function, (2) document the reason for the amendment, and (3) notify any downstream providers who may have received the inaccurate information. ^[12]

Conclusion

HIPAA compliance in AI medical transcription requires deliberate attention to the specific ways that AI workflows handle, process, store, and transmit protected health information. A BAA is the starting point, not the finish line. Organizations that conduct thorough vendor due diligence, implement appropriate internal policies, and require human QA review as a documentation accuracy safeguard will be well-positioned for HIPAA compliance—and for the broader compliance obligations that clinical documentation carries.